MX2016009057A - Liquid vehicle for suspension of undelivered particles. - Google Patents

Liquid vehicle for suspension of undelivered particles.

Info

Publication number
MX2016009057A
MX2016009057A MX2016009057A MX2016009057A MX2016009057A MX 2016009057 A MX2016009057 A MX 2016009057A MX 2016009057 A MX2016009057 A MX 2016009057A MX 2016009057 A MX2016009057 A MX 2016009057A MX 2016009057 A MX2016009057 A MX 2016009057A
Authority
MX
Mexico
Prior art keywords
particles
undelivered
suspension
delivery
liquid vehicle
Prior art date
Application number
MX2016009057A
Other languages
Spanish (es)
Inventor
Paithankar Dilip
V Lando Anthony
Original Assignee
Sebacia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sebacia Inc filed Critical Sebacia Inc
Publication of MX2016009057A publication Critical patent/MX2016009057A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0616—Skin treatment other than tanning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/203—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N7/02—Localised ultrasound hyperthermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0092—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N2007/0004—Applications of ultrasound therapy
    • A61N2007/0034—Skin treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Electromagnetism (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Cosmetics (AREA)
  • Radiation-Therapy Devices (AREA)
  • Surgical Instruments (AREA)

Abstract

The present invention provides compositions comprising energy (e.g., light) absorbing submicron particles (e.g., nanoparticles comprising a silica core and a gold shell) and methods for delivering such particles via topical application. This delivery is facilitated by application of mechanical agitation (e.g. massage), acoustic vibration in the range of 10 Hz-20 kHz, ultrasound, alternating suction and pressure, and microjets. Additionally or optionally, there is a step of applying a sufficient amount of a liquid to the treatment area after substantial evaporation of the formulation leaves a particle residue on the skin surface. Thereafter, one or more steps of facilitating delivery of particles into a portion of the skin are repeated. Finally, the particles are exposed to a suitable energy activation, thereby providing the desired treatment or clinical outcome.
MX2016009057A 2014-01-10 2015-01-09 Liquid vehicle for suspension of undelivered particles. MX2016009057A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461926084P 2014-01-10 2014-01-10
PCT/US2015/010891 WO2015106151A1 (en) 2014-01-10 2015-01-09 Liquid vehicle for suspension of undelivered particles

Publications (1)

Publication Number Publication Date
MX2016009057A true MX2016009057A (en) 2017-02-06

Family

ID=53524384

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016009057A MX2016009057A (en) 2014-01-10 2015-01-09 Liquid vehicle for suspension of undelivered particles.

Country Status (8)

Country Link
EP (1) EP3091920A4 (en)
JP (2) JP2017503861A (en)
KR (1) KR20160119077A (en)
CN (1) CN106170261A (en)
AU (1) AU2015204559B2 (en)
CA (1) CA2935861A1 (en)
MX (1) MX2016009057A (en)
WO (1) WO2015106151A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3005250A1 (en) * 2015-11-13 2017-05-18 Sebacia, Inc. Methods of treating skin conditions using plasmonic nanoparticles
CA3114363A1 (en) * 2018-09-28 2020-04-02 Joel Studin Transpore delivery of steroids and large molecules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923900A (en) * 1985-01-24 1990-05-08 Board Of Regents, The University Of Texas System Therapeutic compositions containing benzoyl peroxide
US20100068232A1 (en) * 2008-08-28 2010-03-18 Key Douglas J Methods for treating skin lines and wrinkles and improving skin quality
CN101698684A (en) * 2009-10-23 2010-04-28 武汉大学 Method for extracting polysaccharose from ginseng and application
PL3222266T3 (en) * 2010-08-27 2018-10-31 Sienna Biopharmaceuticals, Inc. Compositions and methods for targeted thermomodulation
US20130323305A1 (en) * 2012-04-20 2013-12-05 The General Hospital Corporation Compositions and methods comprising energy absorbing materials for follicular delivery
US20130315999A1 (en) * 2012-04-20 2013-11-28 The General Hospital Corporation Compositions and methods comprising energy absorbing compoundfs for follicular delivery

Also Published As

Publication number Publication date
EP3091920A1 (en) 2016-11-16
WO2015106151A1 (en) 2015-07-16
CA2935861A1 (en) 2015-07-16
EP3091920A4 (en) 2017-09-06
AU2015204559B2 (en) 2019-04-18
KR20160119077A (en) 2016-10-12
AU2015204559A1 (en) 2016-07-14
JP2020058787A (en) 2020-04-16
JP2017503861A (en) 2017-02-02
CN106170261A (en) 2016-11-30

Similar Documents

Publication Publication Date Title
MX2016009054A (en) Treatment intervals for use of compositions comprising energy absorbing materials for dermatological applications.
WO2016160622A3 (en) Hla-g as a novel target for car t-cell immunotherapy
EP4011439A3 (en) Device and methods for delivery of stimulation to a body tissue
EP3147285A3 (en) Purinone compounds as kinase inhibitors
WO2015043613A8 (en) Particles comprising a shell with rna
MX2013012458A (en) Intravascular delivery of nanoparticle compositions and uses thereof.
BR112014026012A2 (en) methods for treating or alleviating follicular skin disease, improving the appearance of enlarged pores, permanently removing hair, heat treating hyperhidrosis and facilitating the dispensing of a material
EP3513200A4 (en) Nanoparticles as catalytic substrates for real-time biosensing of human performance and diagnostic and therapeutic methods
WO2015197193A3 (en) New use for jnk inhibitor molecules for treatment of various diseases
EP2974717A3 (en) Use of nano metal in promoting neurite outgrowth and treatment and/or prevention of neurological disorders
JP2015048297A5 (en)
WO2010135521A3 (en) Compositions and methods for the therapy and diagnosis of influenza
MX2016009057A (en) Liquid vehicle for suspension of undelivered particles.
MX2014003957A (en) Assays for ultrasound mediated delivery.
WO2015063613A3 (en) Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
MX2017008330A (en) Products for the delivery of therapeutic/diagnostic compounds to the heart.
WO2016032148A3 (en) Kartogenin-conjugated chitosan particles with improved extended release property and biocompatibility, and use thereof
NZ729408A (en) A method of photochemical internalization (pci) utilizing a antigenic molecule, a photosensitizing agent, and a cytokine
WO2019035144A3 (en) Composition for strengthening the immune system and method of preparation thereof
WO2015184445A8 (en) Cytokine-chitosan bioconjugates and methods of using the same
CN302417017S (en) Pain therapy device
MX2008001575A (en) Process for obtaining a product containing polar lipids and mycobacterial hydrophilic substances from mycobacterium tuberculosis used as a vaccine or immunostimulant.
GB201603364D0 (en) Ultrasonic atomising vibrating micron micro mesh(mmm)disc nicotine drug deliverdevice to be used in the medical nicotine replacement therapy market.
CN302056650S (en) Portable Bioactive Substance Introducer
EA202191901A1 (en) AGGREGATE MICROPARTICLES FOR DRUG THERAPY